CIRM Doles Out $40.6M in Stem Cell Research Funding
On Wednesday, the California Institute for Regenerative Medicine board approved $40.6 million in funding to help researchers at eight California colleges or research universities and one company turn basic discoveries about stem cells into potential therapies. The funded projects include targeted research on Lou Gehrig's disease, muscular dystrophy and Huntington's Disease.
- "Stem Cell Agency Grants $40.6 Million" (Fikes, U-T San Diego, 8/28).
- "New CIRM Payouts Target Muscular Dystrophy, ALS, Huntington's Disease" (Leuty, "BiotechSF," San Francisco Business Times, 8/28).